Kimberly J. Henderson

Clinical and biologic implications of recurrent genomic aberrations in myeloma

Rafaël Fonseca, Emily Blood, Montserrat Rué et al. · Blood · 2003 · 661 citations

Medicine, Genetics, Oncology +14

Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients

Rafaël Fonseca, Emily Blood, Martin M. Oken et al. · Blood · 2002 · 341 citations

Medicine, Hematology, Oncology +11

Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression

Arianna Calcinotto, Arianna Brevi, Marta Chesi et al. · Nature Communications · 2018 · 219 citations · Full text

Life Sciences, Immunology, Microbiology +17

Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study.

Rafaël Fonseca, David Harrington, Martin M. Oken et al. · PubMed · 2002 · 182 citations

Medicine, Hematology, Oncology +16

Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-κB Signaling Pathways in Waldenstrom's Macroglobulinemia

Esteban Braggio, Jonathan J. Keats, Xavier Leleu et al. · Cancer Research · 2009 · 149 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16